Management of Post-Viral Postural Orthostatic Tachycardia Syndrome With Craniosacral Therapy.

autoimmune pots autonomic disturbance craniosacral therapy cv4 neuropathic pots osteopathic manipulative medicine postural orthostatic tachycardia syndrome diagnosis pots and covid vaccine pots covid-19 pots treatment

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Feb 2023
Historique:
accepted: 14 02 2023
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 21 3 2023
Statut: epublish

Résumé

Postural Orthostatic Tachycardia Syndrome (POTS) is a rare disorder of the autonomic nervous system. The number of people afflicted with this dysautonomia has increased dramatically in recent years due to the long-term effects of coronavirus disease (COVID-19); however, it is largely underdiagnosed. This case report is about a patient with post-viral neuropathic POTS. Neuropathic POTS is believed to be due to the damage of small nerve fibers that regulate the constriction of the blood vessels in the limb and abdomen, which leads to interference with vasoconstriction, and therefore causes tachycardia. Current literature emphasizes a treatment that is based on lifestyle modifications, such as increasing water and salt intake, and symptomatic pharmacological treatment. In this case, the 39-year-old male ptient was treated with osteopathic manipulative treatment (OMT), specifically the compression of the fourth ventricle (CV4), which has been associated with the production of hyperparasympathetic and anti-inflammatory effects and, hence, helps overcome the small-fiber neuropathy caused by the viral illness. We found that the CV4 technique led to the successful remission of the patient's symptoms. Therefore, we propose craniosacral therapy as a successful single management modality in patients with POTS.

Identifiants

pubmed: 36938206
doi: 10.7759/cureus.35009
pmc: PMC10021347
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e35009

Informations de copyright

Copyright © 2023, Tafler et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Evid Based Complement Alternat Med. 2017;2017:2974962
pubmed: 29234380
Mayo Clin Proc. 2007 Mar;82(3):308-13
pubmed: 17352367
J Clin Psychol Med Settings. 2018 Dec;25(4):471-484
pubmed: 29508112
J Am Heart Assoc. 2019 Sep 17;8(18):e013602
pubmed: 31495251
Cureus. 2021 May 7;13(5):e14886
pubmed: 34109075
Am J Med Sci. 1999 Feb;317(2):78-87
pubmed: 10037111
J Cardiovasc Electrophysiol. 2009 Mar;20(3):352-8
pubmed: 19207771
Am J Med Sci. 1998 Feb;315(2):95-100
pubmed: 9472908
Front Pediatr. 2019 Nov 07;7:460
pubmed: 31788462
Arch Phys Med Rehabil. 2015 Mar;96(3):505-10
pubmed: 25448247
Nat Commun. 2020 Sep 11;11(1):4541
pubmed: 32917884
Complement Ther Med. 2012 Dec;20(6):456-65
pubmed: 23131379

Auteurs

Leonid Tafler (L)

Primary Care, Touro College of Osteopathic Medicine, New York City, USA.

Aysham Chaudry (A)

Medical School, Touro College of Osteopathic Medicine, Middletown, USA.

Heejin Cho (H)

Primary Care, Touro College of Osteopathic Medicine, New York City, USA.

Angeles Garcia (A)

Medical School, Touro College of Osteopathic Medicine, New York City, USA.

Classifications MeSH